All Stories

  1. Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation

    Article • Drug Design Development and Therapy, February 2015, Taylor & Francis

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  2. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy

    Article • Drug Design Development and Therapy, December 2014, Taylor & Francis

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  3. CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions

    Article • Drug Design Development and Therapy, November 2014, Taylor & Francis

    Dr Mohammadreza Akhavanpoor, Christian Gleißner, Hugo Katus

  4. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

    Article • Drug Design Development and Therapy, September 2014, Taylor & Francis

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  5. A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

    Article • Journal of Visualized Experiments, May 2014, MyJove Corporation

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  6. Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

    Article • Drug Design Development and Therapy, May 2014, Taylor & Francis

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  7. CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+in vitro and in vivo

    Article • Innate Immunity, March 2014, SAGE Publications

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  8. High-sensitive Troponin T measurements early after heart transplantation predict short- and long-term survival

    Article • Transplant International, December 2012, Frontiers

    Christian Gleißner, Dr Mohammadreza Akhavanpoor

  9. PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels

    Article • European Journal of Medical Research, January 2011, Springer Science + Business Media

    Christian Gleißner, Dr Mohammadreza Akhavanpoor